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Purpose or Objective: Catheter reconstruction errors, wrong 
indexer length and misidentified first dwell position are 
among the most common medical events related to high-
dose-rate brachytherapy (HDR-BT) treatment, reported in the 
United States by the Nuclear Regulatory Commission. The 
purpose of this study is a feasibility analysis for the detection 
of such events based on electromagnetic tracking (EMT). 
 
Material and Methods: In a phantom-based experiment 
series, swap of catheters and displacement (Δl = 0, 1, 2, 3, 4, 
5 and 6 mm) of a single catheter along direction of insertion 
were simulated. For the detection of errors the measured 
implant geometry was registered to the nominal one. Then 
the residual distances between corresponding dwell positions 
were analyzed. 
Within an IRB approved study the breast implants of 18 
patients treated with HDR interstitial brachytherapy (HDR-
iBT) were measured by EMT after implantation, after CT 
imaging in imaging position, and as part of each of 9 
treatment fractions in treatment position. The data were 
used to simulate catheter reconstruction errors, wrong 
indexer length, and swapping of catheters. Based on 
determining the pairwise difference of all EMT-reconstructed 
dwell positions and by registering the measured implant 
geometry with the nominal one established during treatment 
planning, the feasibility of error detection by EMT was 
tested. 
 
Results: Swapping of catheters can be detected in phantoms. 
The shift of individual catheters was detected quantitatively 
within the determined EMT-accuracy (95th percentile of 0.83 
mm). For example, the shift of Δl = 6 mm resulted in an EMT-
determined shift of 6.09 mm compared to measured values of 
< 0.8 mm for all catheters without an induced shift. 
First analyses of the data indicate that pairwise differences 
result into a catheter specific “fingerprint” (see figure 1a for 
catheters 5-8). This fingerprint stays stable over multiple 
fractions (figure 1b for DICOM treatment planning, fractions 
2, 4) such that, e.g., a swap as simulated in fraction 4 (fig. 
1b) can easily be identified.  
 
 
 
Conclusion: EMT is a promising technique for error detection 
in interstitial brachytherapy. Further analysis of our clinical 
data will be conducted to determine the sensitivity and 
specificity of the proposed error detection methods.  
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Purpose or Objective: In low dose rate (LDR) brachytherapy, 
seed misplacement/movement is common and may result in 
deviation from the planned dose. Current imaging standards 
for seed position verification are limited in either spatial 
resolution or ability to provide seed positioning information 
during treatment. BrachyView (BV) is a novel, in-body 
imaging system which aims to provide real-time high 
resolution imaging of LDR seeds within the prostate. 
 
Material and Methods: The BV probe consists of a gamma 
camera with three single cone pinhole collimators in a 1 mm 
thick tungsten tube. Three, high resolution, pixelated 
detectors (Timepix) are placed directly below. Each detector 
comprises of 256 x 256 pixels, each 55 × 55 µm2 in area. The 
system is designed to reconstruct seed positions by finding 
the centre of mass of the seed projections on the detector 
plane. Back projection image reconstruction is adopted for 
seed localisation.  
A thirty seed LDR treatment plan was devised. I-125 seeds 
were implanted within a CIRS tissue-equivalent ultrasound 
prostate gel phantom. The prostate volume was imaged with 
transrectal ultrasound (TRUS). The BV probe was placed in-
phantom to image the seeds. A CT scan of the setup was 
performed. CT data were used as the true location of seed 
positions, as well as reference when performing the image 
co-registration between the BV coordinate system and TRUS 
coordinate system.  
An in-house graphical user interface was developed to 
perform 3D visualisation of the prostate volume with the 
seeds in-situ. The BV and CT-derived source locations were 
compared within the prostate volume coordinate system for 
evaluation of the accuracy of the reconstruction method. A 
Dose Volume Histogram (DVH) study of the Clinical Target 
Volume (CTV) was performed using TG-43 calculations, using 
reconstructed source positions provided by BV system and CT 
scanner. 
 
Results: Figure 1 (a) shows the reconstructed prostate 
volume using ultrasound slices. The reconstructed seed 
positions using BV probe and CT images are merged with the 
prostate volume (shown in same coordinate system). (b) 
shows the discrepancy between calculated seed positions 
using CT and BV datasets. (c) shows the DVH calculated from 
CT data set and BV probe. 
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Conclusion: The reconstructed seed positions measured by 
the BV probe demonstrate excellent agreement with seed 
positions calculated using CT data with a maximum 
discrepancy of 1.78 mm. It was observed that 75% of seed 
positions were reconstructed within 1 mm of their nominal 
location. The DVH study was performed to evaluate the 
effect of reconstructed seed locations on estimated dose 
delivered. V100 showed a discrepancy of 0.604 cm3 between 
CT and BV-derived 3D seed distribution. The BV technique 
has proven to be an effective tool for quality assurance 
during LDR brachytherapy, providing anatomical and seed 
positioning information without need for external irradiation 
for imaging. 
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Purpose or Objective: There are multiple challenges behind 
developing an in vivo dosimeter for LDR brachytherapy. The 
dose rates are orders of magnitudes lower than in other 
therapy modalities, the detectors are known to be energy-
dependent, and introducing materials that are not tissue-
equivalent may perturb the dose deposition. The goal of this 
work is to develop a high sensitivity dosimeter based on 
plastic scintillation detectors (PSDs) that overcomes those 
challenges and to validate its performance for in vivo 
dosimetry. 
 
Material and Methods: The effect of the energy dependence 
of PSDs on dosimetry accuracy was studied using GEANT4 
Monte Carlo (MC) simulations adapted from the ALGEBRA 
source code developed for brachytherapy. The photon energy 
distribution at different positions around a modeled I-125 
source was obtained and convoluted to a typical PSD 
response. The effect of the different materials composing the 
PSD was also investigated.  
To measure dose rates as low as 10 nGy/s, the selection of 
each single element composing a typical PSD dosimetry 
system was revisited. A photon-counting photomultiplier tube 
(PMT) was used in combination with an optical fiber designed 
to collect more light from the scintillator. A spectral study 
was performed to determine the best combination of 
scintillator and optical fiber to use.  
Finally, doses up to a distance of 6.5 cm from a single I-125 
source of 0.76U (0.6 mCi) held at the center of a water 
phantom were measured. The PSD was moved at different 
radial and longitudinal positions from the source using an in-
house computer-controlled device developed for this study 
and allowing for sub-mm positioning accuracy. The 
measurements were compared to the expected values from 
the updated Task-Group 43 formalism. 
 
Results: The change in the energy distribution with position 
around the I-125 source was shown from MC simulations to 
have a limited impact on the PSD’s accuracy over the 
clinically relevant range (<1.2%). Therefore, the energy-
dependence can be neglected, as long as the PSD is 
calibrated using the same isotope. The effect of the different 
materials on the photon energy distribution was also shown 
to be limited (<0.1%). The different improvements made to 
the PSD dosimetry system are presented in Table 1. Those led 
to a 44 times better signal-to-noise ratio than for a typical 
PSD. Measurements with the PSD around a single I-125 source 
were shown to be in good agreement with the expected 
values (see Fig.1). The uncertainty was shown to be a 
balance between positioning uncertainty near the source and 
measurement uncertainty as the detector moves farther 
away from the source. 
 
 
 
 
Conclusion: This optimized PSD system was shown to be 
capable of accurate in-phantom dosimetry around a single 
LDR brachytherapy seed, which confirms the high sensitivity 
of the detector as a potential in vivo dosimeter for LDR 
brachytherapy applications. 
 
OC-0254  
MR compatibility of fiber optic sensing for real-time needle 
tracking 
M. Borot de Battisti
1University Medical Center Utrecht, Radiotherapy, Utrecht, 
The Netherlands 
1, B. Denise de Senneville2,3, M. 
Maenhout1, G. Hautvast4, D. Binnekamp4, J.J.W. Lagendijk1, 
M. Van Vulpen1, M.A. Moerland1 
2UMR 5251 CNRS/University of Bordeaux, Mathematics, 
Bordeaux, France 
3University Medical Center Utrecht, Imaging Division, 
Utrecht, The Netherlands 
4Philips Group Innovation, Biomedical Systems, Eindhoven, 
The Netherlands 
